New ETF Book by Larry Connors - Click here to read more
Misys (LSE: MSY), the global application software and services company, announces the launch of Summit Invest, the buy-side derivatives solution that leverages the 20 years of OTC and derivatives expertise of Misys Summit FT.
Misys Summit Invest enables trading, risk management, trade processing and OTC lifecycle management in a tailored buy-side environment. It includes many new features to ensure organisations handle the complexity, risk and regulatory reporting of these complex products. The solution is being deployed this month by a major UK-based Asset Manager. This release along with a strong product roadmap for buy-side signals Misys' commitment to be a significant buy-side solutions provider.
Delivered in a flexible and customisable ASP environment, Summit Invest also meets the need for fast deployment, enabling organisations to be up and running within just a few months. It provides a risk-free and flexible approach that ensures buy-side firms of all sizes are able to afford and benefit from the highest levels of automation of OTCs.
Over recent years, buy-side organisations have faced many challenges manually managing OTCs in systems and spreadsheets that were not designed for this purpose. These businesses have particularly struggled with traditional systems which cannot cope with the complex trade lifecycle and industry demands of these complex instruments. Misys solves this need with Summit Invest, a new solution that consolidates positions across asset classes and includes pricing, risk analysis, collateral management and lifecycle management of OTCs. It combines this proven OTC functionality with new portfolio functionality, valuation techniques and reporting.
"Despite the financial crisis we continue to see interest from buy-side firms who understand they need robust systems for handling these higher risk products," comments David Dixon, Buy-side Solutions Manager at Misys. "Industry research has shown that the trade processing cost of an OTC is between five and 100 times greater than an exchange-traded equity, depending on complexity. Much of this cost is related to the extended lifecycle, which can be 20 years or more. Additionally, the need to automate valuations and processes, such as rate resets and collateral, is particularly strong. The launch of Summit Invest demonstrates our commitment to this growing group of Summit customers that already represents 10% of the Summit customer base."
This announcement builds on a proven track record with hedge funds, asset managers and asset servicers who have purchased the Summit FT solution. Current customers include M&G Investments, Soc Gen Securities Services and Northern Trust.
About Misys plc
Misys plc (LSE: MSY), provides integrated, comprehensive solutions that deliver significant results to organisations in the financial services and healthcare industries. We maximise value for our customers by combining our deep knowledge of their business with our commitment to their success.
In banking and treasury & capital markets, Misys is a market leader, with over 1,200 customers, including all of the world's top 50 banks. In healthcare, Misys plc owns a controlling stake in NASDAQ-listed Allscripts-Misys Healthcare Solutions, Inc, a clear leader in the provision of healthcare technology, serving more than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and homecare organisations. Misys employs around 6,000 people who serve customers in more than 120 countries.
We aspire to be the world's best application software and services company, delivering results for the most important industries in the world.
Misys: experience, solutions, results
Contact us today, visit: http://www.misys.com
For further information please contact
Edward Taylor
Global Head of Public Relations
Misys
Solutions for Banking and Treasury & Capital Markets
+44(0)20-3320-5530
edward.taylor@misys.com
Sebastian Mathews
Financial Dynamics
+44(0)-207-269-7158
sebastian.mathews@fd.com
SOURCE Misys plc
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.